# Resilience US, Inc. – FDA Inspection, May 28, 2009

Source: https://www.keypedia.com/records/fda_inspections/resilience-us-inc/7b596ad0-4510-42d1-905d-68d66c75d54a
Source feed: FDA_Inspections

> FDA inspection 595314 of Resilience US, Inc., May 28, 2009. Classification: Official Action Indicated (OAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 595314
- Company Name: Resilience US, Inc.
- Inspection Date: 2009-05-28
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1102300 - 2019-08-21
- FDA Inspection 1028333 - 2017-09-14
- [FDA Inspection 1021959 - 2017-08-11](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/7149db55-a0d6-45a9-b927-d89a977a24d4)
- [FDA Inspection 897817 - 2014-09-25](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/1b6674da-91e5-456e-afba-1090c029c3cb)
- [FDA Inspection 625796 - 2009-11-13](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/a6cce063-c616-4d41-a6a9-0b9d51829204)

Company: https://www.keypedia.com/companies/resilience-us-inc/f20c4d81-432a-4fb6-9e24-c920285d7419

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c